Advanced or recurrent endometrial cancer

What changed: Advanced or recurrent endometrial cancer

Cancer page →

Every dated change on the records linked to Advanced or recurrent endometrial cancer, newest first: approvals and regulatory steps on its medicines, trials that reported, guideline versions, milestones, and when this page itself was checked. Dates come from the records; none is inferred. Orientation, not medical advice.

Trial result7Milestone6This record1

FollowWatch this cancer and Saved shows what changed since you last looked.Follow by feed

September 2026 · 1

2026-09-17This recordAdvanced or recurrent endometrial cancer
Facts on this page last checked
When this page itself was last checked or edited.

2026 · 2

2025 · 1

2025Trial resultRAINFOL-01 (Rina-S)
RAINFOL-01 (Rina-S) reported
ORR 55.

2024 · 1

2024MilestonePembrolizumab
Pembrolizumab and dostarlimab approved with chemotherapy for all comers
A milestone in how this cancer is treated.

2023 · 5

2021 · 2

2012 · 1

2012MilestoneCarboplatin
GOG-0209: carboplatin-paclitaxel as effective as and less toxic than TAP
A milestone in how this cancer is treated.

1971 · 1

1971MilestoneProgestins (megestrol acetate, medroxyprogesterone, levonorgestrel IUD)
Progestins approved for advanced endometrial cancer
A milestone in how this cancer is treated.